Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Drugs & Targets

CRADA with NCI to expand development of DAY101

October 21, 2022
Vol.48 No.38
Thrice Acting Director Lowy lays out vision of NCI future as Bertagnolli steps in
NCI

Thrice Acting Director Lowy lays out vision of NCI future as Bertagnolli steps in

October 07, 2022
Vol.48 No.36
By Matthew Bin Han Ong
On reporting cancer center catchment area data
FreeLetter To The Editor

On reporting cancer center catchment area data

October 07, 2022
Vol.48 No.36
Monica Bertagnolli: “We must be willing to admit where our efforts have fallen short and be open to new ideas”
Free

Monica Bertagnolli: “We must be willing to admit where our efforts have fallen short and be open to new ideas”

October 07, 2022
Vol.48 No.36
By Matthew Bin Han Ong
25M Americans live outside cancer centers’ catchment areas, AACI-Jefferson study finds
Conversation with The Cancer Letter

25M Americans live outside cancer centers’ catchment areas, AACI-Jefferson study finds

September 30, 2022
Vol.48 No.35
By Matthew Bin Han Ong
In Brief

NCI renews UT Southwestern’s $11.5M program of excellence award in kidney cancer

September 30, 2022
Vol.48 No.35
Lowy’s AACR keynote: “Unacceptable” disparities in cancer outcomes mar 21st century progress
NCI

Lowy’s AACR keynote: “Unacceptable” disparities in cancer outcomes mar 21st century progress

September 23, 2022
Vol.48 No.34
By Matthew Bin Han Ong
In Brief

St. Jude receives Merit Extension Award from NCI

September 23, 2022
Vol.48 No.34
Bypass Budget asks for $9.988B to boost payline, enhance clinical research, deliver on Moonshot promises
Capitol Hill

Bypass Budget asks for $9.988B to boost payline, enhance clinical research, deliver on Moonshot promises

September 16, 2022
Vol.48 No.33
By Jacquelyn Cobb and Paul Goldberg
In Brief

NCI awards five-year, $13.3M grant for collaborative study on sequential combinations of targeted inhibitors, immunotherapies

September 16, 2022
Vol.48 No.33

Posts navigation

Previous1…303132…39Next

Trending Stories

  • Prediction markets now allow betting on clinical trial results, FDA decisions
    It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake
  • Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
    “There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns
  • Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
  • Pour a Scotch, we’re talking clinical trials and prediction markets
  • Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation
  • Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account